Andrew Wei

81PUBLICATIONS
430CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRegenerative medicine (incl. stem cells)Medical virologyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (81)

|Oct 19, 2026
A randomized phase 2 study combining midostaurin, low-dose cytarabine and venetoclax in newly diagnosed AML ≥60 years.

|Sep 02, 2026
MAP3K14 (NIK) synonymous variants drive altered splicing to activate NF-κB in mature B-cell malignancies.

|Jul 13, 2026
Magrolimab Plus Azacitidine Versus Placebo Plus Azacitidine in Patients With Untreated Higher-Risk Myelodysplastic Syndromes: The Phase III ENHANCE Study.

|Jun 04, 2026
ELN-DAVID recommendations for NGS-based FLT3-ITD MRD testing for patients with acute myeloid leukemia.

|Dec 18, 2025
Reduced burden of infection with consecutive day dosing of high dose cytarabine consolidation versus conventional dosing for acute myeloid leukemia.

Alice J Liu, Emily Batterham, Rithin Nedumannil

|Dec 15, 2025
2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party.

Jacqueline Cloos, Peter J M Valk, Christian Thiede

Pageof 14

Frequent Collaborators

23 joint publications

Ing-Soo Tiong

14 joint publications

Courtney D DiNardo

12 joint publications

Pau Montesinos

10 joint publications

Sun Loo